Skip to content

Assessing Experiences With Hemophilia A and B: Patient and Caregiver Interviews

Assessing Experiences with Haemophilia A and B: Patient and Caregiver Interviews

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035630
Enrollment
20
Registered
2021-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D66- Hereditary factor VIII deficiency

Interventions

None listed

Sponsors

Sanofi Aventis Groupe
Lead Sponsor
Kantar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who had participated in phase 3 would be selected from 3 sites. By recruiting patients from multiple sites in India, it is anticipated that the interview substudy sample will be somewhat representative of the overall clinical trial population in India. No patient (or caregiver) clinical or demographic characteristics will be targeted during sample selection.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment

Secondary

MeasureTime frame
To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment

Countries

India

Contacts

Public ContactDr Savita Rangarajan

K J Somaiya Hospital and Research Center

rangarajansavita@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026